Compare VANI & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VANI | GNSS |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.0M | 85.6M |
| IPO Year | 2014 | 1996 |
| Metric | VANI | GNSS |
|---|---|---|
| Price | $1.20 | $1.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $3.50 | ★ $4.75 |
| AVG Volume (30 Days) | ★ 151.4K | 127.2K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.44 |
| EPS | N/A | ★ N/A |
| Revenue | $4,000,000.00 | ★ $26,306,790.00 |
| Revenue This Year | N/A | $80.08 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 29.50 |
| 52 Week Low | $0.92 | $1.40 |
| 52 Week High | $1.92 | $2.70 |
| Indicator | VANI | GNSS |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 39.33 |
| Support Level | $1.13 | $1.40 |
| Resistance Level | $1.25 | $2.06 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 50.00 | 26.05 |
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.